Cell cycle regulators in bladder cancer: A multivariate survival study with emphasis on p27Kip1

被引:75
作者
Korkolopoulou, P
Christodoulou, P
Konstantinidou, AE
Thomas-Tsagli, E
Kapralos, P
Davaris, P
机构
[1] Natl Tech Univ Athens, Dept Pathol, GR-10682 Athens, Greece
[2] Asklepeion Hosp, Dept Pathol, Athens, Greece
[3] Asklepeion Hosp, Dept Urol, Athens, Greece
关键词
p21; p27; p16; pRb; bladder cancer;
D O I
10.1053/hupa.2000.8227
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cyclin-dependent kinase inhibitors (CKIs) prevent cyclin-dependent kinases from phosphorylating critical substrates such as retinoblastoma gene protein (pRb), hence blocking the cascade of events leading to cell proliferation. Currently, the list of CKIs includes p21WAF1/Cip1, p27Kip1, p57Kip2 (the Cip/Kip family), p15/INK4b, p16/INK4a, p18/INK4c, and p19/INK4d (the INK4 family). Among them, p27 plays a crucial role inning extracellular growth-regulatory signals to progression to or exit from the cell cycle. Unlike p53, p16, and Rb, mutations in Kip1 and WAF1 genes are distinctly rare in bladder cancer. We analyzed immunohistochemically the expression of p27 and other interacting G1 proteins (ie, p21, p16, pRb, p53) in 120 consecutive cases of transitional cell carcinomas (TCCs) and related it to proliferation rate, clinicopathologic parameters, and survival. p27 levels were significantly higher in low-grade (P = .001), superficial (Ta-T1) (P = .001), papillary (P < .001), and slowly proliferating TCCs (r(s) = -0.235, P = .05). p27 also positively correlated with p16 expression (r(s) = 0.212, P = .05). In univariate analysis, decreased p27 expression was associated with poor overall (P = .0100) and postrelapse (P = .0344) survival, especially if combined to increased Ki-67 expression (P = .0004 and P = .036, respectively). Furthermore, in multivariate analysis, Ki-67/p27 status had the strongest hearing on the overall survival of muscle-invasive TCCs (P = .0019). Our results indicate that low p27 expression is more common in poorly differentiated muscle-invasive TCCs and is a major player in cell cycle control in these neoplasms. More importantly, the combined Ki-67/p27 expression provides prognostic information beyond that provided by conventional parameters or other cell cycle-related proteins, concerning overall survival in muscle-invasive TCCs. HUM PATHOL 31:751-760. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:751 / 760
页数:10
相关论文
共 43 条
[1]   ABERRATIONS OF P16(INK4) AND RETINOBLASTOMA TUMOR-SUPPRESSOR GENES OCCUR IN DISTINCT SUB-SETS OF HUMAN CANCER CELL-LINES [J].
AAGAARD, L ;
LUKAS, J ;
BARTKOVA, J ;
KJERULFF, AA ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (01) :115-120
[2]   A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers [J].
Akao, T ;
Kakehi, Y ;
Itoh, N ;
Özdemir, E ;
Shimizu, T ;
Tachibana, A ;
Sasaki, MS ;
Yoshida, O .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (11) :1078-1086
[3]   Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer [J].
Benedict, WF ;
Lerner, SP ;
Zhou, J ;
Shen, XH ;
Tokunaga, H ;
Czerniak, B .
ONCOGENE, 1999, 18 (05) :1197-1203
[4]  
CLURMAN BE, 1998, GENETIC BASIS HUMAN, P175
[5]   P53 MUTATIONS IN HUMAN BLADDER-CANCER - GENOTYPIC VERSUS PHENOTYPIC PATTERNS [J].
CORDONCARDO, C ;
DALBAGNI, G ;
SAEZ, GT ;
OLIVA, MR ;
ZHANG, ZF ;
ROSAI, J ;
REUTER, VE ;
PELLICER, A .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :347-353
[6]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[7]   The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].
Epstein, JI ;
Amin, MB ;
Reuter, VR ;
Mostofi, FK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448
[8]  
Erlanson M, 1998, BLOOD, V92, P770
[9]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[10]  
GRANA X, 1995, ONCOGENE, V11, P211